Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyonoski, A. C.
Right arrow Articles by Kirkland, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyonoski, A. C.
Right arrow Articles by Kirkland, J. B.
© 2002 The American Society for Nutritional Sciences J. Nutr. 132:115-120, 2002

Pharmacological Intakes of Niacin Increase Bone Marrow Poly(ADP-Ribose) and the Latency of Ethylnitrosourea-Induced Carcinogenesis in Rats1

Ann C. Boyonoski, Jennifer C. Spronck, Robert M. Jacobs*, Girish M. Shah{dagger}, Guy G. Poirier** and James B. Kirkland2

Department of Human Biology and Nutritional Sciences and * Department of Pathobiology, University of Guelph, Guelph, ON, Canada N1G 2W1; {dagger} Laboratory for Skin Cancer Research, Hospital Research Center of University Laval, Ste. Foy, QC, Canada G1V 4G2; and ** Unit of Health and Environment, Hospital Research Center of University Laval, Ste. Foy, QC, Canada G1V 4G2

2To whom correspondence should be addressed. E-mail: jkirklan{at}uoguelph.ca.

Cancer chemotherapy agents cause short-term leukopenia during treatment and the development of secondary leukemias after recovery from the original disease. We reported that niacin deficiency in rats increases the severity of nitrosourea-induced leukopenia and the subsequent development of cancers. This study was designed to test the effects of supplementing an already high quality diet with pharmacologic levels of niacin. For a period of 4 wk, nontumor-bearing weanling Long-Evans rats were pair-fed AIN-93M diets that were niacin adequate (30 mg/kg diet) or pharmacologically supplemented (4 g/kg diet) with nicotinic acid (NA) or nicotinamide (Nam). One week after the initiation of niacin feeding protocols, ethylnitrosourea (ENU) treatment began (12 doses, 30 mg/kg by gavage, every other day). ENU treatment caused leukopenia, which was not prevented by niacin supplementation. At the end of ENU treatment, all rats were switched to a niacin-adequate diet and monitored. Within 36 wk after the start of treatment, all of the ENU-treated rats either lost 5% of peak body weight or had palpable tumors > 1 cm in diameter, and were necropsied. Supplementation with NA or Nam at 4.0 g/kg diet (combined analysis) increased the latency of the ENU-induced morbidity curve, relative to niacin-adequate controls. Morbidity could be attributed in almost all cases to some form of neoplasm, with leukemias the predominant form. In short-term studies, supplementation with either NA or Nam caused dramatic increases in bone marrow NAD+ (1- to 1.5-fold), basal poly(ADP-ribose) (3- to 5-fold) and ENU-induced poly(ADP-ribose) levels (1.5-fold). These data show that supplementation of a niacin-adequate, high quality diet with pharmacologic levels of nicotinic acid or nicotinamide increases NAD+ and poly(ADP-ribose) levels in bone marrow and may be protective against DNA damage.


KEY WORDS: • niacin • leukemia • nitrosourea • poly(ADP-ribose) • chemotherapy • rats




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. B. Kirkland
Niacin Status Impacts Chromatin Structure
J. Nutr., December 1, 2009; 139(12): 2397 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. B. Kirkland
Niacin status and treatment-related leukemogenesis
Mol. Cancer Ther., April 1, 2009; 8(4): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Sauve
NAD+ and Vitamin B3: From Metabolism to Therapies
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 883 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. S. Young, E. L. Jacobson, and J. B. Kirkland
Water Maze Performance in Young Male Long-Evans Rats Is Inversely Affected by Dietary Intakes of Niacin and May Be Linked to Levels of the NAD+ Metabolite cADPR
J. Nutr., April 1, 2007; 137(4): 1050 - 1057.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2002 by American Society for Nutrition